Delivery Order SPE2DB24D2205-SPE2DB25FEACT

Award Date 3/26/25
Potential Completion Date 3/27/25
Potential Value $2.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,529.68 firm fixed-price delivery order is for the supply of Methazolamide 25 mg tablets. The contract has no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,231.25 firm fixed-price delivery order is for the supply of 4,568,235,107 units of the medication Methazolamide 50 mg tablets. The award is not set-aside and has an ultimate completion date of May 14, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,129.85 Firm Fixed Price Delivery Order contract is for the supply of 4566895532 - METHAZOLAMIDE 50 MG TABLET 100S. The contract is not designated with a set-aside, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, valued at $4,168.92, is for the supply of 4,564,361,959 units of the pharmaceutical product Methazolamide 50 mg Tablet. Amerisourcebergen, a major pharmaceutical distributor, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a wide range of pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,953.54 Firm Fixed Price Delivery Order contract is for the supply of 4,564,743,033 units of Acetazolamide 250 mg tablets, a medication used to treat various medical conditions. The contract has an ultimate completion date of May 30, 2024 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999...
This federal contract award is a delivery order (SPE2DB22D3004|SPE2DB25FQP48) issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,289.40 firm fixed-price contract is for the supply of 4,568,161,238 units of the medication Methazolamide 50 mg tablets, with a performance period through May 7, 2025. The contract is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite...
This federal contract award, with the ID SPE2DX15D6028|SPE2DX25FWJPV, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,673.90 fixed-price delivery order contract is for the provision of 4567516048 - METHYLPHE LA 30MG 100S, a pharmaceutical product. The contract has an ultimate completion date of April 4, 2025. Amerisourcebergen holds a...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract, valued at $20,908.19, is for the delivery of 4,554,642,252 units of the prescription drug Methazolamide 50 mg tablets in quantities of 100 per bottle. The award is a Firm Fixed Price Delivery Order contract with a completion date of September 3, 2021. The contract does not have a set-aside designation, indicating it was...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,035.25 Firm Fixed Price Delivery Order contract is for the supply of METHYLPHENIDATE ER 54 MG TAB 100S, a prescription medication. The contract has an ultimate completion date of November 18, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,699.02 firm fixed-price delivery order is for the supply of 4557681066 methamphetamine 5 mg tablets in 100-count bottles. The contract has an ultimate completion date of June 29, 2022 and is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
  • SPE2DB24D2205
    Indefinite Delivery Contract
  • SPE2DB24D2205-SPE2DB25FEACT
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,245.32 firm fixed-price delivery order is for the supply of 4567706465 ! METHAZOLAMIDE 50 MG TABLET 100S, with a period of performance through March 27, 2025. The contract is not designated as a set-aside.

Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation through May 2024, covering similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies for military personnel, veterans, and other federal beneficiaries.

Generated 6/29/25, 1:18 AM